Stock Quote

ACOR (Common Stock) $ 32.01 -0.25 (-0.78%) Volume: 476,003 MORE May 22, 2015

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *


Firm Analyst
Aegis Capital Yi Chen, Ph.D., CFA
Canaccord Genuity John Newman, Ph.D.
Citigroup Yaron Werber, M.D.
Cowen and Company Phil Nadeau, Ph.D.
ISI Group Mark Schoenebaum, M.D.
J.P. Morgan Cory Kasimov
Leerink Swann Paul Matties
Piper Jaffray Co. Traver Davis
RBC Capital Markets Michael Yee
Robert W. Baird & Co. Christopher J. Raymond
Stifel Nicolaus Thomas Shrader

Acorda Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acorda Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acorda Therapeutics, Inc. or its management. Acorda Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.